Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route
Therapies based on orally administrated nucleic acids have significant potential for the treatment of infectious diseases, including chronic inflammatory diseases such as inflammatory bowel disease (IBD)-associated with the gastrointestinal (GI) tract, and infectious and acute contagious diseases li...
Main Authors: | Fengqian Chen, Qi Liu, Yang Xiong, Li Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.984981/full |
Similar Items
-
Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
by: Dongyoon Kim, et al.
Published: (2021-04-01) -
Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
by: Abu Baker, et al.
Published: (2023-06-01) -
Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers
by: Sagun Poudel, et al.
Published: (2021-07-01) -
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
by: Ruvanthi N. Kularatne, et al.
Published: (2022-07-01) -
Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications
by: Ashish Ranjan Sharma, et al.
Published: (2022-11-01)